Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

NCT04778592 is registered in ClinicalTrials.gov with Eliem Therapeutics (UK) Ltd. as lead sponsor.

NCT NCT04778592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04778592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
Lead sponsor
Eliem Therapeutics (UK) Ltd.
Phase
Phase 2
Overall status
Completed
Start date
January 19, 2021
Completion date
May 25, 2022
Enrollment
149 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

lumbosacral radiculopathy